Hepatitis C virus (HCV) infection affects ceramide metabolism, and, here, we have evaluated
associations of eight serum ceramide species with viral load, viral genotype, and disease …

Hepatic steatosis affects disease progression in patients with chronic hepatitis C virus (HCV)
infection. We investigated the plasma sphingolipid profile in patients with chronic hepatitis C …

The liver plays a central role in the glucose and lipid metabolism. Studies performed on
animal models have shown an important role of lipid accumulation in the induction of insulin …

Background There is growing evidence that ceramides play a significant role in the onset
and progression of non-alcoholic fatty liver disease (NAFLD), a highly prevalent condition in …

Patients after orthopic liver transplantation (OLT) are at risk of developing graft dysfunction.
Sphingolipids (SL's) have been identified to play a pivotal role in the regulation of …

We investigated the relationships between ceramide species concentrations in liver, plasma
and very low‐density lipoproteins (VLDL) particles of humans with obesity as well as the …

Aims This study investigated the association of circulating ceramides in patients with
comorbid acute coronary syndrome and type 2 diabetes mellitus (ACS-DM). Methods A total …

Objective. To assess the association between plasma ceramides and hepatic steatosis (HS)
in adolescents, independently of obesity. Materials and Methods. Ninety‐four adolescents …

Cardiovascular disease (CVD) is a serious comorbidity in nonalcoholic fatty liver disease
(NAFLD). Since plasma ceramides are increased in NAFLD and sphingomyelin, a ceramide …

Background and aims The relationship between ceramides and the risk of mortality among
patients with coronary artery disease (CAD) is currently relatively sparse. This prospective …